Balancing sensitivity and specificity: Sixteen year's of experience from the mammography screening programme in Copenhagen, Denmark

Cancer Epidemiology

Volumn 35, Issue 5, 2011, Pages 393-398

  Utzon Frank, Nicolai ^a   Vejborg, Ilse ^b   von Euler Chelpin, My ^a   Lynge, Elsebeth ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b Mental Health Services CPH   (Denmark)

Author keywords

Benefits; Breast cancer; Mammography; Risks; Screening

Indexed keywords

ADULT; AGED; ARTICLE; ASPIRATION BIOPSY; BREAST BIOPSY; BREAST CANCER; BREAST SURGERY; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER SCREENING; CANCER SURGERY; DENMARK; FALSE POSITIVE RESULT; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; INTRADUCTAL CARCINOMA; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MASS SCREENING; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; SENSITIVITY AND SPECIFICITY; STEREOTACTIC ASPIRATION;

AGED; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, INTRADUCTAL, NONINFILTRATING; DENMARK; EARLY DETECTION OF CANCER; FEMALE; HUMANS; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; PROGNOSIS; SENSITIVITY AND SPECIFICITY; SURVIVAL RATE; TIME FACTORS;

EID: 80052927250     PISSN: 18777821     EISSN: 1877783X     Source Type: Journal    
DOI: 10.1016/j.canep.2010.12.001     Document Type: Article

References (13)

1. European Guidelines for Quality Assurance in Breast Cancer Screening and Diagnosis 2006, European Commision, Bruxelles. 4th ed. N. Perry, M. Broeders, C. de Wolf, S. Törnberg, R. Holland, L. von Karsa (Eds.).
2. Gabe R., Duffy S.W. Evaluation of service screening mammography in practice: the impact on breast cancer mortality. Ann Oncol 2005, 16(Suppl (2)):ii 153-162.
3. Olsen A.H., Njor S.H., Vejborg I., Schwartz W., Dalgaard P., Jensen M.B., et al. Breast cancer mortality in Copenhagen after introduction of mammography screening: cohort study. BMJ 2005, 330(January (7485)):220. [Epub 2005 Jan 13].
4. Day N.E., Williams D.R.R., Khaw K.T. Breast cancer screening programmes: the development of a monitoring and evaluation system. Br J Cancer 1989, 59:954-958.
5. Styregruppen for Dansk Kvalitetsdatabase for Mammografiscreening. [Clinical guidelines for mammography screening in Denmark]. Århus, 2007 [in Danish].
6. [Accessed 11 July 2010]. http://www.cancerscreening.nhs.uk/breastscreen/breast-statistics-bulletin-2007-08.pdf.
7. Hofvind S., Geller B., Vacek P.M., Thoresen S., Skaane P. Using the European guidelines to evaluate the Norwegian breast cancer screening program. Eur J Epidemiol 2007, 22:447-455.
8. Giordano L., Giorgi D., Piccini P., Ventura L., Stefanini V., Senore C., et al. Time trends of process and impact indicators in Italian breast screening programmes: 1998-2007. Epidemiol Prev 2009, 33(Suppl. (2)):29-39.
9. Törnberg S., Kemetli L., Ascunce N., Hofvind S., Anttila A., Sèradour B., et al. A pooled analysis of interval cancer rates in six European countries. Eur J Cancer Prev 2010, 19:87-93.
10. Reynolds A. Stereotactic breast biopsy: a review. Radiol Technol 2009, 80:447M-464M.
11. Duijm L.E.M., Groenewoud J.H., Fracheboud J., et al. Utilization and cost of diagnostic imaging and biopsies following screening mammography in the southern breast cancer screening region of the Netherlands, 2000-2005. Eur Radiol 2008, 18:2390-2397.
12. Jackman R.J., Marzoni F.A., Rosenberg J. False-negative diagnoses at stereotactic vacuum-assisted needle breast biopsy: long-term follow-up of 1,280 lesions and review of the literature. AJR 2009, 192:341-351.
13. Nelson H.D., Tyne K., Naik A., Bougatsos C., Chan B.K., Humphrey L. Screening for breast cancer: an update for the US. Preventive Services Task Force. Ann Intern Med 2009, 151:727-737.